Alzheimer's disease and pharmacological treatments
dc.contributor.advisor | Szentmiklósi, József András | |
dc.contributor.advisordept | Debreceni Egyetem::Általános Orvostudományi Kar::Farmakológiai és Farmakoterápiai Intézet | hu_HU |
dc.contributor.author | Davoodi, Neda | |
dc.contributor.department | DE--Fogorvostudományi Kar | hu_HU |
dc.contributor.opponent | Drimba, László | |
dc.date.accessioned | 2017-09-01T06:04:59Z | |
dc.date.available | 2017-09-01T06:04:59Z | |
dc.date.created | 2015 | |
dc.description.abstract | The defect observed in adults with Alzheimer's disease is likely as a result of a complex interaction of biochemical interactions that ultimately cause neuronal damage.ultimately,our ability for the management of AD depends on having a correct view of the cellular and involved molecular processes as well as having optimal biomarkers to help early diagnosis and therapeutic interventions in patients. | hu_HU |
dc.description.corrector | gj | |
dc.description.course | fogorvos | hu_HU |
dc.description.courselang | angol | hu_HU |
dc.description.degree | MSc/MA | hu_HU |
dc.format.extent | 36 | hu_HU |
dc.identifier.uri | http://hdl.handle.net/2437/243391 | |
dc.language.iso | en | hu_HU |
dc.subject | Alzheimer's disease | hu_HU |
dc.subject | pharmacological treatments | |
dc.subject.dspace | DEENK Témalista::Orvostudomány::Farmakológia | hu_HU |
dc.title | Alzheimer's disease and pharmacological treatments | hu_HU |